The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
CD44 cell adhesion molecules.
Open accessAbstract
The CD44 proteins form a ubiquitously expressed family of cell surface adhesion molecules involved in cell-cell and cell-matrix interactions. The multiple protein isoforms are encoded by a single gene by alternative splicing and are further modified by a range of post-translational modifications. CD44 proteins are single chain molecules comprising an N-terminal extracellular domain, a membrane proximal region, a transmembrane domain, and a cytoplasmic tail. The CD44 gene has only been detected in higher organisms and the amino acid sequence of most of the molecule is highly conserved between mammalian species. The principal ligand of CD44 is hyaluronic acid, an integral component of the extracellular matrix. Other CD44 ligands include osteopontin, serglycin, collagens, fibronectin, and laminin. The major physiological role of CD44 is to maintain organ and tissue structure via cell-cell and cell-matrix adhesion, but certain variant isoforms can also mediate lymphocyte activation and homing, and the presentation of chemical factors and hormones. Increased interest has been directed at the characterisation of this molecule since it was observed that expression of multiple CD44 isoforms is greatly upregulated in neoplasia. CD44, particularly its variants, may be useful as a diagnostic or prognostic marker of malignancy and, in at least some human cancers, it may be a potential target for cancer therapy. This review describes the structure of the CD44 gene and discusses some of its roles in physiological and pathological processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
CD44 and Its Interaction with Extracellular Matrix
Lesley, J., Hyman, R., & Kincade, P. W. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60537-4 · Cited by 1,059
Screaton, G. R., Bell, M. V., Jackson, D. G., Cornelis, F. B., Gerth, U., & Bell, J. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12160 · Cited by 1,015
Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1)
Weber, G. F., Ashkar, S., Glimcher, M. J., & Cantor, H. (1996) · Science · doi:10.1126/science.271.5248.509 · Cited by 949
McKee, C. M., Penno, M. B., Cowman, M., Burdick, M. D., Strieter, R. M., Bao, C., & Noble, P. W. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119054 · Cited by 806
Tsukita, S., Oishi, K., Sato, N., Sagara, J., Kawai, A., & Tsukita, S. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.2.391 · Cited by 779
Stamenkovic, I., Amiot, M., Pesando, J. M., & Seed, B. (1989) · Cell · doi:10.1016/0092-8674(89)90638-7 · Cited by 672
Yonemura, S., Hirao, M., Doi, Y., Takahashi, N., Kondo, T., Tsukita, S., & Tsukita, S. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.4.885 · Cited by 613
Stamenkovic, I., Aruffo, A. A., Amiot, M., & Seed, B. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07955.x · Cited by 573
Requirement for CD44 in Activated T Cell Extravasation into an Inflammatory Site
DeGrendele, H. C., Estess, P., & Siegelman, M. H. (1997) · Science · doi:10.1126/science.278.5338.672 · Cited by 563
Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.
Jalkanen, S., & Jalkanen, M. (1992) · The Journal of cell biology · doi:10.1083/jcb.116.3.817 · Cited by 530
Significance of CD44 gene products for cancer diagnosis and disease evaluation
Matsumura, Y., & Tarin, D. (1992) · The Lancet · doi:10.1016/0140-6736(92)93077-z · Cited by 450
Self-citationExpression and modulation of CD44 variant isoforms in humans
Mackay, C., Terpe, H., Stauder, R., Marston, W., Stark, H., & Günthert, U. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.1.71 · Cited by 437
Bennett, K. L., Jackson, D. G., Simon, J. C., Tanczos, E., Peach, R., Modrell, B., Stamenkovic, I., Plowman, G., & Aruffo, A. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.4.687 · Cited by 427
Participation in Normal Immune Responses of a Metastasis-Inducing Splice Variant of CD44
Arch, R., Wirth, K., Hofmann, M., Ponta, H., Matzku, S., Herrlich, P., & Zöller, M. (1992) · Science · doi:10.1126/science.1496383 · Cited by 403
Yang, B., Yang, B. L., Savani, R. C., & Turley, E. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06261.x · Cited by 383
Identification of hyaluronic acid binding sites in the extracellular domain of CD44
Peach, R., Hollenbaugh, D., Stamenkovic, I., & Aruffo, A. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.257 · Cited by 378
Hofmann‐Apitius, M., Rudy, W., Zöller, M., Tölg, C., Ponta, H., Herrlich, P. A., & Günthert, U. (1991) · PubMed · doi:10.5451/unibas-ep6484 · Cited by 338
Prevention of tumor metastasis formation by anti-variant CD44.
Seiter, S., Arch, R., Reber, S., Komitowski, D., Hofmann, M., Ponta, H., Herrlich, P., Matzku, S., & Zöller, M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.443 · Cited by 334
Bartolazzi, A., Peach, R., Aruffo, A., & Stamenkovic, I. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.53 · Cited by 331
CD44H regulates tumor cell migration on hyaluronate-coated substrate.
Thomas, L., Byers, H. R., Vink, J., & Stamenkovic, I. (1992) · The Journal of cell biology · doi:10.1083/jcb.118.4.971 · Cited by 319
Mohamadzadeh, M., DeGrendele, H., Arizpe, H., Estess, P., & Siegelman, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1604 · Cited by 313
Kohda, D., Morton, C. J., Parkar, A. A., Hatanaka, H., Inagaki, F. M., Campbell, I. D., & Day, A. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80151-8 · Cited by 309
Distinct effects of two CD44 isoforms on tumor growth in vivo.
Sy, M. S., Guo, Y. J., & Stamenkovic, I. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.859 · Cited by 298
Faassen, A. E., Schrager, J. A., Klein, D. J., Oegema, T. R., Couchman, J. R., & McCarthy, J. B. (1992) · The Journal of cell biology · doi:10.1083/jcb.116.2.521 · Cited by 280
Splicing choice from ten variant exons establishes CD44 variability
Tölg, C., Hofmann‐Apitius, M., Herrlich, P. A., & Ponta, H. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.5.1225 · Cited by 279
A Novel Ligand for CD44 Is Serglycin, a Hematopoietic Cell Lineage-specific Proteoglycan
Toyama-Sorimachi, N., Sorimachi, H., Tobita, Y., Kitamura, F., Yagita, H., Suzuki, K., & Miyasaka, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7437 · Cited by 275
Bourguignon, L. Y. W., Gunja-Smith, Z., Iida, N., Zhu, H. B., Young, L. J. T., Muller, W. J., & Cardiff, R. D. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199807)176:1<206::aid-jcp22>3.0.co;2-3 · Cited by 270
Yu, Q., Toole, B. P., & Stamenkovic, I. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.1985 · Cited by 250
Jackson, D. G., Bell, J. I., Dickinson, R., Timans, J., Shields, J., & Whittle, N. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.4.673 · Cited by 249
Lokeshwar, V. B., Fregien, N., & Bourguignon, L. Y. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.4.1099 · Cited by 248
Screaton, G. R., Bell, M. V., Bell, J. I., & Jackson, D. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31376-0 · Cited by 243
Bourguignon, L. Y. W., Zhu, H., Chu, A., Iida, N., Zhang, L., & Hung, M.-C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27913 · Cited by 237
CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor
Stauder, R., Eisterer, W., Thaler, J., & Gunthert, U. (1995) · Blood · doi:10.1182/blood.v85.10.2885.bloodjournal85102885 · Cited by 221
Inhibition of tumor growthin vivo by hyaluronan oligomers
Zeng, C., Toole, B. P., Kinney, S. D., Kuo, J.-W., & Stamenkovic, I. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980729)77:3<396::aid-ijc15>3.0.co;2-6 · Cited by 215
Trochon, V., Mabilat, C., Bertrand, P., Legrand, Y., Smadja-Joffe, F., Soria, C., Delpech, B., & Lu, H. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960529)66:5<664::aid-ijc14>3.0.co;2-4 · Cited by 211
Lesley, J., English, N., Perschl, A., Gregoroff, J., & Hyman, R. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.431 · Cited by 196
Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44
Legg, J. W., & Isacke, C. M. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70277-5 · Cited by 186
Birch, M., Mitchell, S., & Hart, I. R. (1991) · PubMed · Cited by 182
Glutamylation of centriole and cytoplasmic tubulin in proliferating non-neuronal cells
Bobinnec, Y., Moudjou, M., Fouquet, J. P., Desbruyères, E., Eddé, B., & Bornens, M. (1998) · Cell Motility and the Cytoskeleton · doi:10.1002/(sici)1097-0169(1998)39:3<209::aid-cm4>3.0.co;2-# · Cited by 182
Identification of CD44 Residues Important for Hyaluronan Binding and Delineation of the Binding Site
Bajorath, J., Greenfield, B., Munro, S. B., Day, A. J., & Aruffo, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.338 · Cited by 182
Dougherty, G. J., Landorp, P. M., Cooper, D. L., & Humphries, R. K. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.1.1 · Cited by 178
CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation
DeGrendele, H. C., Kosfiszer, M., Estess, P., & Siegelman, M. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.6.2549 · Cited by 168
Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator
Konig, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2904 · Cited by 159
Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.
Sleeman, J. P., Rudy, W., Hofmann‐Apitius, M., Moll, J., Herrlich, P. A., & Ponta, H. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.135.4.1139 · Cited by 157
Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons.
Bennett, K. L., Modrell, B., Greenfield, B., Bartolazzi, A., Stamenkovic, I., Peach, R., Jackson, D. G., Spring, F. A., & Aruffo, A. A. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.6.1623 · Cited by 155
Knutson, J. R., Iida, J., Fields, G. B., & McCarthy, J. B. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.3.383 · Cited by 153
New CD44 splice variants associated with human breast cancers
Iida, N., & Bourguignon, L. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041620115 · Cited by 137
Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury.
Jain, M. K., He, Q. W., Lee, W. S., Kashiki, S., Foster, L. C., Tsai, J. C.-S., Lee, M. E., & Haber, E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118455 · Cited by 133
Regulation of CD44-Protein 4.1 Interaction by Ca2+and Calmodulin
Nunomura, W., Takakuwa, Y., Tokimitsu, R., Krauss, S. W., Kawashima, M., & Mohandas, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30322 · Cited by 125
CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression
Bourguignon, L., Zhu, D., & Zhu, H. (1998) · Frontiers in bioscience · doi:10.2741/a308 · Cited by 124
Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein.
Sy, M. S., Guo, Y. J., & Stamenkovic, I. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.2.623 · Cited by 122
Lesley, J., Kincade, P. W., & Hyman, R. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230826 · Cited by 121
Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells
Burg, M. A., Grako, K. A., & Stallcup, W. B. (1998) · Journal of Cellular Physiology · Cited by 118
Estess, P., DeGrendele, H. C., Pascual, V., & Siegelman, M. H. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4235 · Cited by 104
Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent.
Zahalka, M. A., Okon, E., Gosslar, U., Holzmann, B., & Naor, D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.10.5345 · Cited by 102
Interaction between CD44 and osteopontin as a potential basis for metastasis formation.
Weber, G. F., Ashkar, S., & Cantor, H. (1997) · PubMed · Cited by 101
A PCR-based method for the analysis of human CD44 splice products.Preprint
van Weering, D. H. J., Baas, P. D., & Bos, J. L. (1993) · Genome Research · doi:10.1101/gr.3.2.100 · Cited by 95
Bourguignon, L., Kalomiris, E. L., & Lokeshwar, V. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99022-8 · Cited by 92
Green, S. J., Tarone, G., & Underhill, C. B. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90393-x · Cited by 92
CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis
Ayroldi, E., Cannarile, L., Migliorati, G., Bartoli, A., Nicoletti, I., & Riccardi, C. (1995) · Blood · doi:10.1182/blood.v86.7.2672.2672 · Cited by 89
Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
Sleeman, J. P., Arming, S., Moll, J. F., Hekele, A., Rudy, W., Sherman, L. S., Kreil, G., Ponta, H., & Herrlich, P. (1996) · PubMed · Cited by 87
Katoh, S., McCarthy, J. B., & Kincade, P. W. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.8.3440 · Cited by 87
To metastasize or not? Selection of CD44 splice sites
Cooper, D. L., & Dougherty, G. J. (1995) · Nature Medicine · doi:10.1038/nm0795-635 · Cited by 87
Toyama‐Sorimachi, N., Kitamura, F., Habuchi, H., Tobita, Y., Kimata, K., & Miyasaka, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26714 · Cited by 84
Goldstein, L. A., & Butcher, E. C. (1990) · Immunogenetics · doi:10.1007/bf00241632 · Cited by 83
Salles, G., Zain, M., Jiang, W., Boussiotis, V., & Shipp, M. (1993) · Blood · doi:10.1182/blood.v82.12.3539.3539 · Cited by 80
Liao, H., Lee, D. M., Levesque, M., & Haynes, B. F. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3938 · Cited by 78
Henke, C. A., Bitterman, P. B., Roongta, U. V., Ingbar, D. H., & Polunovsky, V. A. (1996) · Europe PMC (PubMed Central) · Cited by 77
Gansauge, F., Gansauge, S., Zobywalski, A., Scharnweber, C., Link, K. H., Nussler, A. K., & Beger, H. G. (1995) · PubMed · Cited by 72
Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells
Galluzzo, E., Albi, N., Fiorucci, S., Merigiola, C., Ruggeri, L., Tosti, A., Grossi, C. E., & Velardi, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251033 · Cited by 72
Liu, D., & Sy, M. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.5.1987 · Cited by 69
Reeder, J. A., Gotley, D. C., Walsh, M. D., et al. (1998) · PubMed · Cited by 69
Boyer, C., Xu, F. J., Mills, G., O'Briant, K. C., Bast, R. C., Jr., Whitaker, R., Stack, S., & Yu, Y. H. (2022) · PubMed · doi:10.7274/24742149 · Cited by 66
The CD44 Proteins in Embryonic Development and in Cancer
Sherman, L. S., Sleeman, J. P., Dall, P., Hekele, A., Moll, J., Ponta, H., & Herrlich, P. A. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-61107-0_15 · Cited by 64
Gorham, H. C., Sugino, T., Woodman, A., & Tarin, D. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.6.482 · Cited by 33
Self-citationWeiss, J. M., Renkl, A. C., Sleeman, J. P., Dittmar, H. C., Termeer, C., Taxis, S., Howells, N., Schöpf, E., Ponta, H., Herrlich, P. A., et al. (1998) · Cell Communication & Adhesion · doi:10.3109/15419069809004472 · Cited by 32
Cited by
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Cell Encapsulation in Biodegradable Hydrogels for Tissue Engineering Applications
Nicodemus, G. D., & Bryant, S. J. (2008) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2007.0332 · Cited by 1,239
Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis
Pittayapruek, P., Meephansan, J., Prapapan, O., Komine, M., & Ohtsuki, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060868 · Cited by 1,099
Huang, E. H., Hynes, M. J., Zhang, T., Ginestier, C., Dontu, G., Appelman, H., Fields, J. Z., Wicha, M. S., & Boman, B. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4418 · Cited by 1,045
Senbanjo, L. T., & Chellaiah, M. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00018 · Cited by 842
Metadata
- Authors
- Goodison, S., Urquidi, V, & Tarin, D.
- Venue
- Molecular Pathology
- Publisher
- BMJ
- Published
- 1999-08
- Volume
- 52
- Issue
- 4
- Pages
- 189-196
- ISSN
- 1366-8714 (ISSN-L)
- 1472-4154
- OpenAlex
- W2037100155
- Cited by
- 679
- References
- 77
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.